• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Neostem, Inc. (NBS)

    -NasdaqCM
    2.88 Down 0.07(2.37%) May 22, 4:00PM EDT
    |After Hours : 2.84 Down 0.04 (1.39%) May 22, 7:56PM EDT
    Add to Portfolio
    Prev Close:2.95
    Open:3.11
    Bid:N/A
    Ask:3.02 x 500
    1y Target Est:13.50
    Beta:0.55
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:2.66 - 3.15
    52wk Range:2.15 - 7.23
    Volume:3,510,210
    Avg Vol (3m):535,761
    Market Cap:115.63M
    P/E (ttm):N/A
    EPS (ttm):-1.72
    Div & Yield:0.06 (1.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NBS

    Comparison

    Symbol% ChgMkt Cap
    NBSDown 2.37%115.63M
    BAXDown 0.25%36.67B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.36
    Quarterly EPS Est (Jun-15) :-0.33
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.04

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback